Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
Abstract:
The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
Information query
Patent Agency Ranking
0/0